← Leaderboards
Clifton Barry
National Institute Of Allergy And Infectious Diseases
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Tuberculosis”
- Judith S. Currier · University Of California Los Angeles$301,722,065
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$297,204,160
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$267,912,117
- Lawrence Corey · Fred Hutchinson Cancer Center$255,939,398
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$200,192,298
- Sharon A Nachman · Johns Hopkins University$194,852,226
Research focus
TuberculosisMycobacterium TuberculosisPharmaceutical PreparationsTuberculosis TreatmentChemotherapyLesionIn VivoMetabolismResponseBacteriaClinical TrialsCollaborationsTuberculosis DrugsLungEnzymesBaseDrug ResistanceOryctolagus CuniculusRegimenCell WallMonitorReportingSeriesTreatment Protocols
Grant awards (78)
Development Of New Chemotherapeutics For Tuberculosis$1,691,247
ZIA · FY2025 · AI · contact PI
Experimental Animal Models of TB: Chemotherapeutics and Imaging$993,273
ZIA · FY2025 · AI · contact PI
International Tuberculosis Clinical Research$487,751
ZIA · FY2025 · AI · contact PI
Development Of New Chemotherapeutics For Tuberculosis$1,829,520
ZIA · FY2024 · AI · contact PI
Experimental Animal Models of TB: Chemotherapeutics and Imaging$1,413,031
ZIA · FY2024 · AI · contact PI
International Tuberculosis Clinical Research$1,276,926
ZIA · FY2024 · AI · contact PI
Experimental Animal Models of TB: Chemotherapeutics and Imaging$1,642,641
ZIA · FY2023 · AI · contact PI
Development Of New Chemotherapeutics For Tuberculosis$1,642,641
ZIA · FY2023 · AI · contact PI
International Tuberculosis Clinical Research$1,034,058
ZIA · FY2023 · AI · contact PI
Development Of New Chemotherapeutics For Tuberculosis$1,538,298
ZIA · FY2022 · AI · contact PI
Experimental Animal Models of TB: Chemotherapeutics and Imaging$1,538,298
ZIA · FY2022 · AI · contact PI
International Tuberculosis Clinical Research$1,011,326
ZIA · FY2022 · AI · contact PI
Development Of New Chemotherapeutics For Tuberculosis$1,179,135
ZIA · FY2021 · AI · contact PI
Experimental Animal Models of TB: Chemotherapeutics and Imaging$1,179,135
ZIA · FY2021 · AI · contact PI
International Tuberculosis Clinical Research$964,717
ZIA · FY2021 · AI · contact PI
Experimental Animal Models of TB: Chemotherapeutics and Imaging$1,469,455
ZIA · FY2020 · AI · contact PI
Development Of New Chemotherapeutics For Tuberculosis$1,469,455
ZIA · FY2020 · AI · contact PI
International Tuberculosis Clinical Research$1,089,343
ZIA · FY2020 · AI · contact PI
Experimental Animal Models of TB: Chemotherapeutics and Imaging$1,444,144
ZIA · FY2019 · AI · contact PI
Development Of New Chemotherapeutics For Tuberculosis$1,444,144
ZIA · FY2019 · AI · contact PI
International Tuberculosis Clinical Research$1,145,241
ZIA · FY2019 · AI · contact PI
Experimental Animal Models of TB: Chemotherapeutics and Imaging$1,261,081
ZIA · FY2018 · AI · contact PI
Development Of New Chemotherapeutics For Tuberculosis$1,261,081
ZIA · FY2018 · AI · contact PI
International Tuberculosis Clinical Research$1,071,829
ZIA · FY2018 · AI · contact PI
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis$653,552
ZIA · FY2017 · AI · contact PI
International Tuberculosis Research in China$538,199
ZIA · FY2017 · AI · contact PI
Tuberculosis studies in South Africa$525,226
ZIA · FY2017 · AI · contact PI
Experimental Animal Models of TB: Chemotherapeutics and Imaging$525,226
ZIA · FY2017 · AI · contact PI
Exploring the metabolism of non-replicating and drug-resistant TB$525,226
ZIA · FY2017 · AI · contact PI
Development Of New Chemotherapeutics For Tuberculosis$525,226
ZIA · FY2017 · AI · contact PI
CAP: Development of a Tuberculosis-Specific PET Imaging Agent$182,687
ZIA · FY2017 · AI · contact PI
Development Of New Chemotherapeutics For Tuberculosis$1,329,738
ZIA · FY2016 · AI · contact PI
Experimental Animal Models of TB: Chemotherapeutics and Imaging$1,306,989
ZIA · FY2016 · AI · contact PI
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis$616,559
ZIA · FY2016 · AI · contact PI
Exploring the metabolism of non-replicating and drug-resistant TB$591,469
ZIA · FY2016 · AI · contact PI
Tuberculosis studies in South Africa$500,474
ZIA · FY2016 · AI · contact PI
International Tuberculosis Research in China$467,138
ZIA · FY2016 · AI · contact PI
CAP: Development of a Tuberculosis-Specific PET Imaging Agent$159,242
ZIA · FY2016 · AI · contact PI
Exploring the metabolism of non-replicating and drug-resistant TB$756,479
ZIA · FY2015 · AI · contact PI
Experimental Animal Models of TB: Chemotherapeutics and Imaging$756,479
ZIA · FY2015 · AI · contact PI
Development Of New Chemotherapeutics For Tuberculosis$756,479
ZIA · FY2015 · AI · contact PI
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis$729,683
ZIA · FY2015 · AI · contact PI
International Tuberculosis Research in China$476,482
ZIA · FY2015 · AI · contact PI
CAP: Development of a Tuberculosis-Specific PET Imaging Agent$252,160
ZIA · FY2015 · AI · contact PI
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis$608,042
ZIA · FY2014 · AI · contact PI
Development Of New Chemotherapeutics For Tuberculosis$581,288
ZIA · FY2014 · AI · contact PI
Experimental Animal Models of TB: Chemotherapeutics and Imaging$581,288
ZIA · FY2014 · AI · contact PI
Exploring the metabolism of non-replicating and drug-resistant TB$581,288
ZIA · FY2014 · AI · contact PI
International Tuberculosis Research in China$462,630
ZIA · FY2014 · AI · contact PI
CAP: Development of a Tuberculosis-Specific PET Imaging Agent$193,763
ZIA · FY2014 · AI · contact PI
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis$701,341
ZIA · FY2013 · AI · contact PI
Development Of New Chemotherapeutics For Tuberculosis$599,050
ZIA · FY2013 · AI · contact PI
Experimental Animal Models of TB: Chemotherapeutics and Imaging$599,050
ZIA · FY2013 · AI · contact PI
Exploring the metabolism of non-replicating and drug-resistant TB$599,050
ZIA · FY2013 · AI · contact PI
International Tuberculosis Research in China$431,263
ZIA · FY2013 · AI · contact PI
CAP: Development of a Tuberculosis-Specific PET Imaging Agent$199,683
ZIA · FY2013 · AI · contact PI
Exploring the metabolism of non-replicating and drug-resistant TB$655,103
ZIA · FY2012 · AI · contact PI
Experimental Animal Models of TB: Chemotherapeutics and Imaging$635,835
ZIA · FY2012 · AI · contact PI
Development Of New Chemotherapeutics For Tuberculosis$635,835
ZIA · FY2012 · AI · contact PI
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis$572,969
ZIA · FY2012 · AI · contact PI
International Tuberculosis Research in China$465,555
ZIA · FY2012 · AI · contact PI
CAP: Development of a Tuberculosis-Specific PET Imaging Agent$268,168
ZIA · FY2012 · AI · contact PI
Exploring the metabolism of non-replicating and drug-resistant TB$1,286,564
ZIA · FY2011 · AI · contact PI
Experimental Animal Models of TB: Chemotherapeutics and Imaging$1,002,104
ZIA · FY2011 · AI · contact PI
Development Of New Chemotherapeutics For Tuberculosis$1,002,104
ZIA · FY2011 · AI · contact PI
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis$784,326
ZIA · FY2011 · AI · contact PI
International Tuberculosis Research in China$410,901
ZIA · FY2011 · AI · contact PI
Exploring the metabolism of non-replicating and drug-resistant TB$1,611,276
ZIA · FY2010 · AI · contact PI
Experimental Animal Models of TB: Chemotherapeutics and Imaging$1,611,276
ZIA · FY2010 · AI · contact PI
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis$1,331,243
ZIA · FY2010 · AI · contact PI
Development Of New Chemotherapeutics For Tuberculosis$1,289,021
ZIA · FY2010 · AI · contact PI
International Tuberculosis Research in China$896,499
ZIA · FY2010 · AI · contact PI
Exploring the metabolism of non-replicating and drug-resistant TB$1,624,089
ZIA · FY2009 · AI · contact PI
Experimental Animal Models of TB: Chemotherapeutics and Imaging$1,624,089
ZIA · FY2009 · AI · contact PI
Development Of New Chemotherapeutics For Tuberculosis$1,299,271
ZIA · FY2009 · AI · contact PI
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis$898,320
ZIA · FY2009 · AI · contact PI
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis$1,153,780
Z01 · FY2008 · AI · contact PI
International Research in Nigeria: Traditional TB remedies from Africa$110,627
Z01 · FY2008 · AI · contact PI